Stay updated on Empagliflozin Effects on Cardiac Structure in T2D Clinical Trial
Sign up to get notified when there's something new on the Empagliflozin Effects on Cardiac Structure in T2D Clinical Trial page.

Latest updates to the Empagliflozin Effects on Cardiac Structure in T2D Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check20 days agoChange DetectedAdds a new version tag (v3.2.0) and removes several drug-related topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and an older version tag (v3.0.2).SummaryDifference0.3%
- Check21 days agoChange DetectedAdded update: Revision: v3.1.0; Removed topics: Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs, and Revision: v3.0.2. Overall, safety/drug-related sections were removed while a new version label was added.SummaryDifference0.3%
- Check36 days agoChange DetectedThe page now shows Revision: v3.0.2 (replacing v3.0.1) and the Back to Top element has been removed.SummaryDifference0.2%
- Check43 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.2%
- Check51 days agoChange DetectedThe web page has undergone significant updates, including the addition of new research articles related to diabetes and empagliflozin, as well as the removal of previous content on certain diabetes-related topics and location details.SummaryDifference9%
- Check65 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
Stay in the know with updates to Empagliflozin Effects on Cardiac Structure in T2D Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Empagliflozin Effects on Cardiac Structure in T2D Clinical Trial page.